… No approved chronic weight management medications … type 2 diabetes. The primary objective
of this study was to assess the effect of liraglutide 3.0 mg versus placebo on weight loss in …

… weight reduction was dose-dependent (p = 0.007) and liraglutide was not effective in patients
with BMI >45 kg/m 2 . … level significantly correlated with HbA1c reduction. Lower leptin and …

… diabetes (T2D) mellitus. Herein, we aimed to assess the 5-year effectiveness of Liraglutide in
the management of weight … overweight/obese T2D patients, who were naïve to GLP-1 RAs. …

… one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity
and … the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes. …

… In summary, the efficacy and safety of liraglutide 3.0 mg for weight management were generally
… effects on body weight, cardiometabolic risk factors and health-related quality of life. With …

… A1C and weight reduction between both groups. There was a significant lower frequency of
withdrawals due to all causes and a nonsignificant lower rate of vomiting and hypoglycemia …

… hypothesized that patients with type 2 diabetes and ESRD tolerate treatment with liraglutide
in … of an acceptable weight loss must be performed prior to initiation of liraglutide treatment in …

… therapy improves glycemic control with a low risk of hypoglycemia, and is associated with
significant weight loss in patients with T2DM. These observations are consistent with clinical …

… The weight loss of 4.4 kg after 6 months of liraglutide treatment in the present study is
more than the mean maximum weight loss of 2.8 kg reported in most previous randomized …

… respectively of liraglutide as compared to a weight loss of 2.2% … Interestingly, an early weight
loss in treatment with liraglutide … efficacy in weight loss: we considered a mild effect a weight …